Annals of Hepatology

Beyond hazard ratios: interpreting trial endpoints and survival analysis in systemic therapy for hepatocellular carcinoma Federico Piñero; Stephen L. Chan; Arndt Vogel;

Screening and management for portal hypertension in hepatocellular carcinoma: A nationwide survey in China Xueyan Li; Huiyu Chen; Qingqing Zhang; Shaotong Wang; Youping Wang; Yixuan Chen; Jun Song; Mingkai Chen;

Data mining reveals novel gene drivers of lenvatinib resistance in hepatocellular carcinoma Cyrollah Disoma; Claudio Tiribelli; Caecilia Sukowati;